Market Closed -
Bombay S.E.
06:13:41 2022-10-06 EDT
|
5-day change
|
1st Jan Change
|
8.36
INR
|
-4.89%
|
|
-.--%
|
-.--%
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,361
|
1,173
|
438.4
|
410.8
|
431.5
|
524.3
|
Enterprise Value (EV)
1 |
796.4
|
674.1
|
-140.8
|
140.4
|
86.4
|
55.22
|
P/E ratio
|
374
x
|
-19.4
x
|
-4.19
x
|
-0.71
x
|
-4.05
x
|
-6.48
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.56
x
|
1.23
x
|
0.76
x
|
30.9
x
|
3,269
x
|
-
|
EV / Revenue
|
0.91
x
|
0.71
x
|
-0.24
x
|
10.6
x
|
655
x
|
-
|
EV / EBITDA
|
-56.3
x
|
-10.1
x
|
1.15
x
|
-0.52
x
|
-0.69
x
|
-0.54
x
|
EV / FCF
|
-20.4
x
|
-10.9
x
|
-1.72
x
|
-2.2
x
|
4.61
x
|
0.39
x
|
FCF Yield
|
-4.91%
|
-9.18%
|
-58.2%
|
-45.4%
|
21.7%
|
255%
|
Price to Book
|
1.34
x
|
1.24
x
|
0.52
x
|
1.52
x
|
2.64
x
|
6.33
x
|
Nbr of stocks (in thousands)
|
62,715
|
62,715
|
62,715
|
62,715
|
62,720
|
62,715
|
Reference price
2 |
21.70
|
18.70
|
6.990
|
6.550
|
6.880
|
8.360
|
Announcement Date
|
18-06-20
|
19-08-09
|
20-07-18
|
21-07-08
|
22-08-19
|
23-08-23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
870.8
|
953.3
|
578.5
|
13.28
|
0.132
|
-
|
EBITDA
1 |
-14.15
|
-66.95
|
-122.4
|
-271.9
|
-124.7
|
-102.2
|
EBIT
1 |
-32.83
|
-90.92
|
-149.4
|
-290.9
|
-124.9
|
-102.4
|
Operating Margin
|
-3.77%
|
-9.54%
|
-25.82%
|
-2,190.46%
|
-94,597.73%
|
-
|
Earnings before Tax (EBT)
1 |
0.42
|
-61.17
|
-102.8
|
-576.4
|
-107.8
|
-75.94
|
Net income
1 |
3.643
|
-60.4
|
-104.7
|
-577.2
|
-106.5
|
-80.93
|
Net margin
|
0.42%
|
-6.34%
|
-18.1%
|
-4,345.66%
|
-80,693.94%
|
-
|
EPS
2 |
0.0581
|
-0.9632
|
-1.670
|
-9.203
|
-1.700
|
-1.290
|
Free Cash Flow
1 |
-39.12
|
-61.86
|
81.99
|
-63.71
|
18.74
|
140.9
|
FCF margin
|
-4.49%
|
-6.49%
|
14.17%
|
-479.66%
|
14,200.38%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-06-20
|
19-08-09
|
20-07-18
|
21-07-08
|
22-08-19
|
23-08-23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
565
|
499
|
579
|
270
|
345
|
469
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-39.1
|
-61.9
|
82
|
-63.7
|
18.7
|
141
|
ROE (net income / shareholders' equity)
|
0.36%
|
-6.16%
|
-11.7%
|
-104%
|
-49.1%
|
-65.7%
|
ROA (Net income/ Total Assets)
|
-1.89%
|
-5.29%
|
-9.62%
|
-28.8%
|
-19.4%
|
-13.1%
|
Assets
1 |
-192.3
|
1,142
|
1,088
|
2,002
|
549.6
|
619.6
|
Book Value Per Share
2 |
16.10
|
15.10
|
13.40
|
4.310
|
2.610
|
1.320
|
Cash Flow per Share
2 |
0.2100
|
0.1700
|
0.1500
|
0.3200
|
0.3300
|
0.6400
|
Capex
1 |
53.3
|
55.7
|
28.3
|
0.21
|
-
|
-
|
Capex / Sales
|
6.12%
|
5.85%
|
4.89%
|
1.54%
|
-
|
-
|
Announcement Date
|
18-06-20
|
19-08-09
|
20-07-18
|
21-07-08
|
22-08-19
|
23-08-23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 6.28M | | +16.96% | 66.52B | | +2.81% | 50.34B | | +17.88% | 42.01B | | +20.88% | 26.68B | | +11.82% | 19.97B | | +0.72% | 17.32B | | -21.87% | 15.7B | | +0.91% | 15.53B | | -10.63% | 14.99B |
Other Specialty Chemicals
|